ABSTRACT In early Drosophila embryos, germ plasm is localized to the posterior pole region and is partitioned into the germline progenitors, known as pole cells. Germ plasm contains the maternal factors required for germline development. It has been proposed that germline-specific gene expression is initiated by the function of maternal factors that are enriched in the germ plasm. However, such factors have remained elusive. Here, we describe a genome-wide survey of maternal transcripts that encode for transcription factors and are enriched in the germ plasm. We isolated pole cells from blastodermal embryos by fluorescence-activated cell sorting (FACS) and then used these isolated cells in a microarray analysis. Among the 835 genes in the Gene Ontology (GO) category "transcription regulator activity" listed in FlyBase, 68 were found to be predominantly expressed in pole cells as compared to whole embryos. As the early pole cells are known to be transcriptionally quiescent, the listed transcripts are predicted to be maternal in origin. Our in situ hybridization analysis revealed that 27 of the 68 transcripts were enriched in the germ plasm. Among the 27 transcripts, six were found to be required for germline-specific gene expression of vasa and/or nanos by knockdown experiments using RNA interference (RNAi). The identified transcripts encode a transcriptional activator (ovo), components of the transcriptional initiation complexes (Trf2, bip2 and Tif-IA), and the Ccr4-Not complex (CG31716 and l(2)NC136). Our study demonstrates that germ plasm contains maternal transcripts encoding transcriptional regulators for germline-specific gene expression in pole cells.
Introduction
Identifying the mechanisms underlying germline establishment is a century-old issue in developmental biology. In the animal species, there are at least two distinct modes of germline establishment (Extavour and Akam, 2003) . In certain animal species, germline progenitors are characterized by inheriting a specialized ooplasm, or germ plasm, that contains the maternal factors required for and sufficient for germline development (Beams and Kessel, 1974; Eddy, 1975; Rongo and Lehmann, species, and that their expression is a marker for germline establishment. However, how the germline-specific gene expression is activated within the germline progenitors has remained unclear.
In Drosophila, the germ plasm is localized to the posterior pole region of the cleavage embryos (stage 1-2) and is partitioned into pole cells (stage 3). The pole cells move during midgut rudiment gastrulation, pass through the midgut epithelium to associate with the somatic gonadal precursors (stage 6-12), and then aggregate with the somatic cells to form the embryonic gonads by stage 15. Expression of vas begins in the pole cells immediately after gastrulation and is the earliest example of gene expression in the germline progenitors (Van Doren et al., 1998) . Once initiated, vas expression continues in the germline cells (Hay et al., 1988a; Hay et al., 1988b; Lasko and Ashburner, 1990) . Later, zygotic expression of nos becomes detectable in the pole cell within the embryonic gonads. Although the role of zygotic vas and nos in pole cells remains obscure, their expression makes them ideal markers to analyze how germline-specific gene expression is initiated in the pole cells.
Germline-specific gene expression is thought to be activated by maternal factors localized in the germ plasm. To date, several maternal factors have been identified whose functions are required for early events in germline development (Mahowald, 2001) . For example, the mitochondrial large ribosomal RNA and the BTB/POZ protein Germ cell-less (Gcl) are both involved in pole cell formation (Iida and Kobayashi, 1998; Robertson et al., 1999) . Likewise, the maternal RNA binding protein Nos is essential to repress mitosis, apoptosis, and somatic differentiation of pole cells (Asaoka-Taguchi et al., 1999; Hayashi et al., 2004; Sato et al., 2007) . polar granule component (pgc) RNA is required for pole cell survival (Nakamura et al., 1996; Martinho et al., 2004) . Pole cells also require trapped in endoderm-1 (Tre1), a maternal RNA encoding a G-protein-coupled receptor that is required for their transepithelial movement through the midgut wall (Kunwar et al., 2003) . Furthermore, several maternal transcripts enriched in germ plasm have been additionally identified by in situ hybridization screens (Szuperák et al., 2005; Sato et al., 2007) . However, neither genetic nor molecular screens have yet identified any maternal factors that encode for transcriptional regulators involved in germline-specific pole cell gene expression.
Here, we describe the identification of maternal RNAs that are enriched in the germ plasm and encode for transcription factors. We utilize RNAi knockdown to investigate transcription factor function for germline-specific vas and nos expression in pole cells. Six transcripts were found to be required for vas and/or nos gene expression. These transcripts encode for a transcriptional activator (ovo), for transcriptional initiation complex components (Trf2, bip2 and Tif-IA), and for the Ccr4-Not complex (CG31716 and l(2)NC136). This study provides an important first step toward understanding gene regulation in pole cells and suggests that these identified maternal factors may be involved in germline development by regulating pole cell gene expression.
Results and Discussion

A screen for candidate transcripts enriched in early pole cells
To identify novel maternal transcripts enriched in the Drosophila germ plasm, we compared the transcriptome from pole cells and from whole embryos at stage 4 by microarray analysis. First, fluorescence-activated cell sorting (FACS) was used to isolate pole cells from embryos carrying the transgene EGFP-vasa, which express GFP specifically in the germline. RNA was extracted from the isolated pole cells and from the whole embryos. These RNA isolates were amplified and labeled with Cy3 and Cy5, and hybridized to a microarray containing oligo probes for all of the predicted protein-coding genes in Drosophila genome. After filtering out any probe sets with low quality results, e.g. low signal intensity and high variance between the dye-swap experiments (see Materials and Methods for details), we identified candidate transcripts enriched in pole cells (Fig. 1 ). In this screen, maternal transcripts known to be enriched in the germ plasm and in pole cells were identified. RNA transcripts for nos, gcl, Tre1 and pgc were detected at 13.7-, 5.5-, 4.1-and 11.5-fold higher levels respectively in pole cells when compared to whole embryos (Fig.  1) . These results suggest that maternal transcripts enriched in pole cells were successfully identified by the microarray analysis, even though only a single RNA sample was screened in the microarray analysis due to the technical difficulty of obtaining RNA from the sorted pole cells.
In this study, we focused on the genes encoding for transcription factors because they represent probable candidates for maternal regulators of pole-cell gene expression. Among the 835 genes in the Gene Ontology (GO) category "transcription regula- , P = pole-cell-signal intensity, W = whole-embryo-signal intensity. The filled circles (black, brown, orange and blue) represent the transcripts encoding a transcription regulator (GO:0030528). The brown, orange and blue circles show the transcript expression examined by in situ hybridization. Orange and blue: the transcripts enriched in the germ plasm (Table 1) . Blue: the transcripts with dsRNA that caused a decrease in pole cell vas and/or nos expression (Table 3) . Green: the transcripts which have been identified to be enriched in the germ plasm and in pole cells. Open circles: the remaining protein-coding transcripts encoded by the Drosophila nuclear genome.
To validate our WISH data, we compared the expression pattern of the 27 genes with the expression annotation and the representative images in the Fly-FISH (http://flyfish.ccbr.utoronto.ca/) and BDGP Gene Expression Report (http:/ /www.fruitfly.org/cgi-bin/ex/insitu.pl) which include expression data for 3370 and 6138 genes, respectively (Tomancak et al., 2002; Lécuyer et al., 2007) . Among the 27 genes, 10 and 15 have been analyzed for their expression by Fly-FISH and BDGP, respectively. Seven out of the 10 and 6 out of the 15 are reported to be expressed in the germ plasm and/or pole cells at stage 4-5, and the remaining genes were classified as either "ubiquitously expressed" or "undetectable expression" (Supplementary Table  S2 ). In contrast, among the 38 genes that were identified in our microarray analysis but not selected by our WISH screen, none (0/18 in Fly-FISH and 0/16 in BDGP) were reported as enriched in either the germ plasm or pole cells (data not shown). These observations suggest that our WISH analysis is almost compatible with those previously performed. Additionally, we succeeded to identify novel transcripts that are enriched in the germ plasm and/or pole cells (Fig. 2 
Distribution of the selected transcripts in early embryos
Because RNA polymerase II-dependent transcription is globally repressed in early pole cells (Seydoux and Dunn, 1997) , the 68 transcripts selected from the microarray analysis were predicted to be maternal in origin and present in the germ plasm. As a next step, whole-mount in situ hybridization (WISH) analysis was performed to select for the transcripts that are enriched in germ plasm. We obtained useful expression data for the 65 transcripts (see Materials and Methods), and we found that the transcripts from 27 genes were enriched in the germ plasm of cleavage embryos (Table 1 , Fig. 2 ). Of the selected 27 genes, 63% (17/27) showed high signal intensities in microarray hybridization (A-value ≥ 8.0; A = log 2 , P = pole-cell-signal intensity, W = whole-embryo-signal intensity), while the majority (89%) of the 38 genes not enriched in germ plasm showed low signal intensities (A-value < 8.0) (Fig. 1) . Thus, at low expression, differential microarray hybridization levels were influenced by background noise in our microarray analysis. 
Distribution
GENES ENCODING THE TRANSCRIPTS ENRICHED IN GERM PLASM
* The embryos were in situ hybridized with the probes for the listed genes. Hybridization signals were observed at a high (+), a low (±) and an undetectable level (-) in the germ plasm (GP), pole cells at stage 4/5 (PC), migrating pole cells (mPC) and pole cells within the gonads (gPC).
rgr, Tra1, Rel, NC2alpha, ref(2)P, Pcl, CG31716, Hcf, H, zfh1, Smox, CG5640, l(2)NC136 and ttk] were no longer detectable by in situ hybridization in pole cells during their migration to the embryonic gonads. However, Zyx102EF and zfh1 were again detected in pole cells within the embryonic gonads, suggesting that these two genes were expressed zygotically within the gonads. All of the genes, except for CG10445 and Arc70, were also expressed zygotically in the somatic tissues, such as the midgut, mesoderm, and the central nervous system (Fig. 2) .
RNAi screen to determine maternal transcript requirement for germline-specific gene expression The 27 maternal transcripts were further screened by RNAi for their possible function in germline-specific gene expression. RNAi has been increasingly exploited to knockdown target RNA levels and to explore gene function in vivo and in cultured cells . In Drosophila, transgenes expressing double-stranded RNA (dsRNA) are used to knockdown gene function in vivo, and UAS-RNAi lines which target many Drosophila genes are now readily available (Akasaka et al., 2006; Kobayashi et al., 2006; Yang et al., 2006; Dietzl et al., 2007) . Here, however, dsRNA targeting each maternal transcript was injected into cleavage embryos to diminish the activity from each maternal transcript. The germline-specific expression of vas and nos genes in pole cells was then examined. Instead of expressing dsRNAs later in pole cells, this "injection" method takes advantage of the opportunity to target maternal transcripts immediately after oviposition and thus effectively reduce their function (Sato et al., 2007) . In normal embryos, zygotic vas and nos expression is initiated in pole cells approximately at stages 9 and 15, respectively. Their expression continues to be detectable until at least the end of embryogenesis. Hence, vas and nos gene expression in dsRNA-injected embryos was examined at stage 15-16 [26 hr after egg laying (AEL) at 18ºC].
DsRNA-injected embryos were allowed to develop at 18°C until 26 hr AEL, and then RNAibased screen in two steps. First, vas and nos expression was examined promptly and without regard to their developmental status in order to identify required candidate transcripts (Table 2) . Second, a detailed analysis of the dsRNA-induced phenotype against the candidate transcripts was performed with regard to embryonic development, pole cell development, pole cell transcriptional ability, and expression of the germlinespecific genes in pole cells (Tables 3-5) . Taken together, these two steps identified six transcripts whose dsRNAs significantly decreased the per-centage of the stage 15-16 embryos expressing vas and/or nos in pole cells (Table  3 , Fig. 3) .
A significant reduction in the amount of the six transcripts were evident, when their dsRNAs were injected into embryos ( Supplementary Fig. S1 ). Injection of dsRNAs targeting the transcripts of bip2, ovo, CG31716 and Trf2 repressed both vas and nos expression. l(2)NC136 dsRNA repressed vas expression, while Tif-IA dsRNA suppressed nos expression in pole cells. None of the six dsRNAs against these transcripts except CG31716 and Trf2 affected embryonic development (Table  4) , including pole cell formation, pole cell migration, and gonad formation. The expected population of pole cells was incorporated within the embryonic gonads of the injected embryos at stage 15-16 (Fig.  3 , data not shown). Table 4 shows that the injection of CG31716 dsRNA slightly reduced the percentage of embryos developing to stage 15-16, but, in the surviving embryos, the pole cells colonized normally within the gonads (Fig. 3 , data not shown). Although Trf2 dsRNA injection retarded embryonic development during germ band shortening in 60-90% of the embryos (Table  3 -5), the embryos that survived to stage 15-16 showed no defects in pole cell development (Fig. 3 , data not shown). Pole cells in the stage 15-16 embryos that were injected with each of the six dsRNA had retained a normal ability to express the UAS-lacZ transgene under maternally supplied Gal4 (Table 5) . The above data suggest that repression of the germline-specific gene expression is not caused by an indirect effect of the injected dsRNAs on the embryonic development or on the transcriptional machinery.
Overview of the identified transcripts
The above data suggest that vas and nos expression is regulated by the combination of transcription factors encoded by the germ plasm-enriched maternal transcripts. The identified transcripts encode for a transcriptional activator (ovo), for components of the transcriptional initiation complexes (Trf2, bip2 and Tif-IA), and for the Table 1 ). Anterior is to the left.
Ccr4-Not complex (CG31716 and l(2)NC136).
It is worthwhile to note that this screen identified at least two genes, ovo and Trf2, that have been reported to be required for oogenesis. Genetic screens have identified many maternally acting genes required for early germline development (Mahowald, 2001 ). However, these screens could only recover mutations that did not affect oogenesis, and therefore failed to identify many maternal genes that play a critical role both in oogenesis and embryonic germline development. In this study, we injected dsRNA into early embryos to examine the role of maternal transcripts in germline-specific gene expression. This method enabled us to circumvent the oogenesis defects and screen for phenotypes in embryos. Detailed functions of the identified six genes are discussed below.
A transcriptional activator, ovo
The maternal ovo transcript was enriched in the germ plasm and was required for vas and nos expression in pole cells. The ovo gene encodes for a developmentally regulated, DNA-binding, C 2 H2 Zn-finger protein that is involved in oogenesis (Oliver et al., 1987; Mével-Ninio et al., 1991; Staab and Steinmann-Zwicky, 1996) and in denticle formation in the epidermal cells (Wieschaus et al., 1984) . The ovo gene produces at least three alternate isoforms. Ovo-A and Ovo-B function as a negative and a positive transcriptional regulator in the germline, respectively (Andrews et al., 2000) . Ovo-Svb is expressed in the epidermal cells and is required for their differentiation (Payre et al., 1999; Delon et al., 2003) . Ovo-B protein activates transcription from the ovarian tumor (otu) and ovo-B promoters in a germline-specific manner via binding to the short regions proximal to their transcriptional start site (Lü and Oliver, 2001; Bielinska et al., 2005) . Ovo-B binding to the core promoter region suggests that this protein could interact with the initiation complex TFIID at the same region, either directly or indirectly (Lü and Oliver, 2001 ). Thus, we postulate that Ovo-B, along with TFIID components, initiates germline-specific expression of vas and nos in pole cells.
The role of maternal ovo in germline development remains elusive, since ovo dsRNA injection caused lethality at the end of embryogenesis due to the defect in epidermal differentiation (data not shown) which requires zygotic ovo function (Oliver et al., 1987) . Embryos injected with ovo dsRNA did not show any deleterious defects in pole cell development during embryogenesis. Thus, we speculate that the pole cells with reduced maternal ovo activity may be impaired in their post-embryonic development. Future work is needed to test this consideration by transplanting the pole cells with reduced ovo activity into normal hosts.
Components of the transcriptional initiation complex
In the fly, frog, and mouse, Trf2 is predominantly expressed in the germline cells during gametogenesis in both females and males (Kopytova et al., 2006; Xiao et al., 2006) . Trf2 expression is required for proper Drosophila development of both oocytes and spermatocytes (Kopytova et al., 2006) and for spermatogenesis in mice (Zhang et al., 2001) . Although Trf2 is additionally required for somatic development in Drosophila embryos (Kopytova et al., 2006) , its function in the germline is evolutionarily conserved. * y w embryos were used as recipients for dsRNA microinjection.
$ The injected embryos were stained for vas or nos RNA. No. of the embryos expressing vas or nos RNA in pole cells at a high (+), a low (±) and an undetectable level (-) are shown.
# P > 0.05, ## 0.05 > P > 0.01, ### P < 0.01; Significance was calculated vs. DW-injected control by using Fisher's exact probability test.
TABLE 2
EXPRESSION OF VAS AND NOS RNA IN POLE CELLS OF THE dsRNA-INJECTED EMBRYOS
Trf2 encodes a TATA box-binding protein (TBP)-related factor (Rabenstein et al., 1999) . TBP and TBP-associated factors (TAFs) are known to be components of an initiation complex that recognizes the core promoter sequences (Tjian and Maniatis, 1994; Bell and Tora, 1999) . Recent data suggest that Trf2 is involved in the formation of a TFIID-like complex to regulate the expression of a set of genes in a cell-type-specific manner (Hochheimer et al., 2002) . Trf2 has been shown to associate with restricted loci on chromosomes at sites different from those of TBP (Rabenstein et al., 1999) . Furthermore, the TRF2-containing complex includes components of the chromatin-remodeling complex, NURF, and other proteins that might be involved in chromatin reorganization (Hochheimer et al., 2002) . Considering that the trf2 transcript is enriched in germ plasm and is required for vas and nos expression in pole cells, it is reasonable to speculate that Trf2 may regulate germline-specific genes via the rearrangement of chromatin organization and/or the formation of distinctive TFIID-like complexes.
This idea is supported by the observation that the transcript encoding one of the TAFs, Bric-a-brac interacting protein 2 (BIP2, also called as TAFII155), is enriched in the germ plasm (Fig. 2) and is required for vas and nos expression in pole cells (Fig. 3 , Table 3 ). TAFs have been known to act as specific coactivators by interacting with transcriptional activators, and TAFs contribute to promoter recognition and selectivity (Verrijzer et al., 1994; Burke and Kadonaga, 1997) . BIP2 was first identified as a partner of the Bric à brac 2 (Bab2) protein (Pointud et al., 2001) . BAB2 interacts with BIP2 via BTB/POZ domains, and these two proteins colocalize at transcriptionally active regions of polytene chromosomes (Pointud et al., 2001) . BAB2 acts as a developmentally regulated transcriptional activator involved in the morphogenesis of the somatic components of adult ovaries (Couderc et al., 2002) . Although the transcriptional activators interacting with BIP2 in early pole cells remain unknown, the above observations suggests that the TFIID-like complex containing TRF2 and BIP2 is involved in the initiation of germline-specific gene expression.
Components of Ccr4-Not complex
Here, we show that transcripts from CG31716 and l(2)NC136 are both enriched in the germ plasm and required for vas expression in pole cells. CG31716 and l(2)NC136 encode for the proteins NOT4 and NOT3/5, respectively, and both are components of the Ccr4-NOT complex (Collart, 2003) . The Ccr4-Not complex is evolutionarily conserved from yeast to human. By potentially interacting with many different proteins, the Ccr4-NOT complex regulates various cellular functions, including transcriptional initiation, RNA metabolism, and protein modification (Collart, 2003) . In yeast, NOT5 of the Ccr4-NOT complex can associate with promoters and is involved in transcriptional regulation by interacting with TAF1 (Deluen et al., 2002) . Although transcriptional regulation by the Ccr4-NOT complex remains unclear in Drosophila, it is possible that this complex may be directly responsible for vas transcription. Alternatively, it is also possible that the Ccr4-NOT complex is involved in RNA turnover or in the translational regulation that is required for vas expression in pole cells, because the Twin/Ccr4-NOT complex is required for these molecular events during Drosophila development (Morris et 
VIABILITY OF THE EMBRYOS INJECTED WITH dsRNAS
* y w embryos were used as recipients for dsRNA microinjection.
$ No. of the injected embryos normally developing to stage 15/16 were scored.
# P > 0.05, ## P < 0.01; Significance was calculated vs. GFP control by using Fisher's exact probability test.
2005; Wharton and Aggarwal, 2006; Kadyrova et al., 2007) . In this regard, it is interesting to note that the maternal RNA binding protein Nos recruits the Ccr4-NOT complex in order to repress the translation of specific mRNAs (Kadyrova et al., 2007) . We have previously reported that maternal Nos represses translation of cyclin-B and head involution defective (hid) RNAs in pole cells to suppress their mitosis and apoptosis (Asaoka-Taguchi et al., 1999; Sonoda and Wharton, 2001; Sato et al., 2007) . Moreover, maternal Nos is required for vas expression in pole cells, suggesting that Nos could prevent the production of a protein which and Stefanovsky, 2002; Grummt, 2003) . TIF-IA acts as the key regulator for rRNA transcription by recruiting RNA polI into the rRNA promoter pre-initiation complex, and the interaction between TIF-IA and RNA polI is regulated by various pathways linking biosynthetic activities (Moss and Stefanovsky, 2002; Grummt, 2003) . In early pole cells, RNA polII-dependent transcription is globally inhibited by maternal Pgc (Martinho et al., 2004) , but RNA polI-dependent transcription remains active (Seydoux and Dunn, 1997) . Furthermore, the observed rate of protein synthesis is higher in pole cells than in the rest of somatic otherwise inhibits vas expression in pole cells (Sano et al., 2001) . Thus, it is likely that the Ccr4-NOT complex regulates vas expression via Nos-dependent translational repression.
Our results show that injection of the dsRNA for CG31716 but not for l(2)NC136, also affects nos expression in pole cells (Table 3) . Perhaps CG31716 has another role in nos expression that is independent of Ccr4-NOT function. Alternatively, it is also possible that pole cells express a gene which shares a redundant function with l(2)NC136 in order to regulate nos expression.
A transcriptional initiation factor for RNA polymerase I
We found that Tif-IA RNA is enriched in pole cells and is required for nos expression but not vas expression. Tif-IA encodes a Drosophila ortholog of yeast Rrn3p and mammalian TIF-IA, both of which are the initiation factor for RNA polymerase I (RNA polI) ( 
region in blastodermal embryos (Zalokar, 1976) . Thus, we suggest that the pole cell-enriched Tif-IA RNA could then upregulate rRNA transcription and protein synthesis in these cells. It is possible that zygotic expression of nos requires a higher rate of protein synthesis than that of vas.
Conclusion
In this study, we performed a genome-wide survey of the maternal transcripts that are enriched in the germ plasm and that encode for transcriptional regulators. We identified 27 maternal transcripts based on microarray and in situ hybridization data. These results will allow us to understand the molecular basis for germ plasm function, although elucidation of specific processes regulated by each of the identified genes awaits future genetic analyses. We further utilized RNAi knockdown to investigate the role of the identified transcripts in germline-specific gene expression. Six transcripts were found to be required for vas and/or nos expression. This study demonstrates that the germ plasm contains maternal RNAs encoding for transcription factors that are required for germline-specific gene expression in pole cells.
Materials and Methods
Fly stocks
Pole cells were isolated from EGFP-vas embryos by FACS. This method efficiently enables us to obtain fractions highly enriched for pole cells . For in situ hybridization and RNAi analyses, y w files were used. To examine lacZ expression in pole cells, the nosGal4:VP16 and UAS-lacZ lines were used (Van Doren et al., 1998) . Flies were raised on a standard Drosophila medium at 25°C. Embryos were staged according to Campos-Ortega and Hartenstein (1997) .
Microarray analysis
Total RNA was extracted from pole cells isolated from the stage 4 syncytial-blastoderm embryos as described . As a reference, total RNA was also extracted from stage 4 whole embryos using an RNeasy Mini kit (QIAGEN). Transcript profiles between these RNA samples were then compared by microarray analysis which was performed as described (Sato et al., 2007) . Extracted RNA was amplified as cRNAs labeled with cyanine-3 CTP (Cy3) and cyanine-5 CTP (Cy5) using Agilent Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies, Palo Alto, CA). Custommade 22K 60-mer oligo microarrays (Agilent) that contain 21,925 probes representing almost all of the predicted Drosophila transcripts were used (Sato et al., 2007) (GPL4336) . Each array was hybridized with 1 µg of both Cy3-labeled and Cy5-labeled cRNA and washed according to the Agilent protocol. The dye-swap experiment was also carried out. Subsequently, the arrays were scanned with a G2565BA Microarray Scanner System (Agilent). Data were analyzed using the Feature Extraction 7.1 software (Agilent). LOWESS (20%) normalization was applied to the data using GeneSpring software (Agilent). The probe sets with low signal intensity (normalized value < 10) or with high variance between the dye-swap experiments (variance between Cy3/ Cy5 and Cy5/Cy3 ratios >75%) were excluded, and data for 18,205 probes was used for the subsequent analysis. The data will be deposited in GEO under Accession No. GSE9679.
We selected 735 as "candidate transcripts enriched in pole cells "based on their differential microarray hybridization levels (pole cell to whole embryo ratios ≥ 1.56; when dual microarray probes were designed to hybridize single transcripts, the higher ratios were used for the selection). Among them, 68 were classified in the GO category "transcriptional regulator activity" in FlyBase (Release 3.1). GO annotation was based on the gene association file (version 2004-7) provided by GO consortium (http://www.geneontology.org/). These selected genes showed a wide variety of pole cells to whole embryo ratios ranging from 1.56 to 8.60.
In situ hybridization
Whole-mount in situ hybridization was essentially performed as described (Mukai et al., 2006) . DIG-labeled antisense RNA probes were synthesized with T3 RNA polymerase from flanked PCR products amplified from pBluescript SK(+) containing the cDNA fragments and with T7 and T3 primers. The cDNA fragments corresponding to the identified 68 transcripts were amplified from an embryonic cDNA library (Brown and Kafatos, 1988) by using the primer pairs listed in Supplementary Table S1 . Each primer pair was designed to amplify approximately 1 kb of cDNA fragment corresponding to a 3'-portion of the open reading frame. Under the conditions used, we failed to amplify the cDNAs corresponding to Doc1, CG3711, and CG31782. Thus, we examined the distribution of the other 65 transcripts by whole-mount in situ hybridization.
The probe for lacZ (1.1 kb) was synthesized as previously described (Fatchiyah Zubair et al., 2006) .
Signal detection was carried out using an alkaline phosphataseconjugated anti-DIG Fab fragment (Roche). Color development was performed using 0.45 mg/ml NBT and 0.18 mg/ml BCIP at 25ºC for 1-6 hr in the dark.
Microinjection of dsRNAs
Template DNA fragments flanked by T7 and T3 promoter sequences at each end were amplified from the same cDNA clones used for in situ hybridization using the primer pair 5'-TAATACGACTCACTATAGGG-3' and 5-GTAATACGACTCACTATAGGGCTCACTAAAGGGAACAAAAGC-3'. The T7 promoter sequence is underlined and the T3 promoter is in bold. dsRNA was synthesized from the templates with T7 RNA polymerase (MEGAscript Kit, Ambion). As a control, we also synthesized dsRNA from a GFP cDNA fragment [679-1398 of pEGFP-N1 vector (Clontech) (accession No. = U556762)]. Approximately 0.1 nl of dsRNA solution (3 ng/nl in distilled water) was injected into the poster region of cleavage embryos (stage 2). The injected embryos were allowed to develop until stage 15-16 (26 hr AEL at 18ºC) and were fixed for in situ hybridization.
RT-PCR analysis
The dsRNA-injected embryos were allowed to develop until stage 3-4 (2 hr AEL at 18ºC). Total RNA was isolated from 30 of the injected embryos using the RNeasy Mini Kit (QIAGEN). First-strand cDNA was synthesized from the RNA using oligo dT primer and SuperScript III RT (Invitrogen). Pairs of primers used for detecting bip2, ovo, Tif-IA, CG31716, Trf2, l(2) NC136 and RpL32 are listed in Supplementary  Table S3 . The thermal cycling condition was as follow: 1 cycle of 94˚C for 5 minutes, then 30 cycles of 94˚C for 15 seconds, 60˚C for 30 seconds, 68˚C for 1 minute. RpL32 was used as a control. The embryos produced from nosGal4:VP16 females (Van Doren et al., 1998) crossed with UAS-lacZ males were used as recipients for dsRNA microinjection. Microinjection of dsRNA and in situ hybridization using the β-gal probe were carried out as described above. 
